Glaucoma is the second leading cause of blindness worldwide, affecting ~80 million people by 2020 (1, 2). The condition is characterized by a progressive loss of retinal ganglion cells (RGCs) and their axons accompanied by visual field loss. The underlying pathophysiology of glaucoma remains elusive. Glaucoma is recognized as a multifactorial disease, and lowering intraocular pressure (IOP) is the only treatment that has been shown to slow the progression of the condition. However, a significant number of glaucoma patients continue to go blind despite intraocular pressure-lowering treatment (2). Thus, the need for alternative treatment strategies is indisputable. Accumulating evidence suggests that glial cells play a significant role in supporting RGC function and that glial dysfunction may contribute to optic nerve disease. Here, we review recent advances in understanding the role of glial cells in the pathophysiology of glaucoma. A particular focus is on the dynamic and essential interactions between glial cells and RGCs and potential therapeutic approaches to glaucoma by targeting glial cells.
* Shared co‐author.
Purpose: Previous cerebral studies of Alzheimer's disease (AD) have provided evidence for a neuronal metabolic dysfunction, which precede the cognitive decline. Since the retina is one of the most energy demanding tissues in the body and considered an extension of the brain due to its origin from the neural tissue, we speculate whether dysfunctional energy metabolism is present in AD models. Thus, the aim of the study is to evaluate energy metabolism and tissue survival in retinal explants in a murine model of AD (TgSwDI) during aging.
Methods: The 8‐, 12‐, and 24‐month‐old TgSwDI mouse model was compared with age‐matched wild‐type (WT) mice. Tissue survival was assessed by lactate dehydrogenase (LDH) viability assays of retinal explants at 2, 4 and 24 hours of incubation with culture media. Total ATP levels were quantified by bioluminescence assays to assess energy metabolism in TgSwDI mice.
Results: Retinal explant survival was reduced in the TgSwDI model compared to the age‐matched WT model with LDH assay at 8 months. The 8‐month‐old AD TgSwDI mice showed a tendency to decrease in total ATP levels after 2 hours of retinal explant incubation (p = 0.07).
Conclusions: Retinal tissue survival is impaired in the TgSwDI model during various ages, and tendencies of decreased retinal ATP levels were established at 8 months, implying disrupted retinal energy metabolism similar to changes observed in the AD brain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.